How many institutions held DYNT - MACROGENICS, INC. - Common Stock, par value $0.01 per share in Q1 2024?

9 institutional investors reported DYNT - MACROGENICS, INC. - Common Stock, par value $0.01 per share for Q1 2024. Use the holders table for investor-level position and value details.

MACROGENICS, INC. - Common Stock, par value $0.01 per share (DYNT)

Q: What does CUSIP 268157500 represent in this 13F holders report?

CUSIP 268157500 is the security identifier for DYNT - MACROGENICS, INC. - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

CUSIP: 268157500

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock, par value $0.01 per share
Total 13F shares: 177,213
Total 13F value: $78,966
Share change: -26,975
SEC-reported price per share: $0.45
Number of holders: 9
Value change: -$15,047
Number of buys: 3
Number of sells: 5
Shares outstanding: 63,551,797

Security key

268157500

Report period

Q1 2024

Institutions

Top holders

DYNT full security history Ownership snapshot Full 13F holder table MACROGENICS INC SEC filings MACROGENICS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DYNT - MACROGENICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Bellevue Group AG

Disclosed value leader

Bellevue Group AG

Comparable rows

15/15

Latest evidence

31 Dec 2023

13F Lead comparable stake: 16% Showing 1-6 of 15 holder rows.

Quick read

Bellevue Group AG leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bellevue Group AG's linked filing trail.

Comparable ownership Top 5

Bellevue Group AG 16%

T. Rowe Price Investment Manageme... 8.8%

ARMISTICE CAPITAL, LLC 7.2%

RA CAPITAL MANAGEMENT, L.P. 6.3%

Frazier Life Sciences Management,... 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bellevue Group AG	13F Company 13F	16%	$95,750,871 9,953,313 shares	—	31 Dec 2023
T. Rowe Price Investment Management, Inc.	13F Company 13F	8.8%	$54,257,000 5,639,994 shares	—	31 Dec 2023
ARMISTICE CAPITAL, LLC	13F Company 13F	7.2%	$43,982,640 4,572,000 shares	—	31 Dec 2023
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	6.3%	$38,990,601 4,053,077 shares	—	31 Dec 2023
Frazier Life Sciences Management, L.P.	13F Company 13F	3.8%	$23,104,392 2,401,704 shares	—	31 Dec 2023
STATE STREET CORP	13F Company 13F	3.4%	$20,914,092 2,174,022 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

177,213

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %